September 11, 2024 by University of Cincinnati Credit: Unsplash/CC0 Public DomainA study published in the journal Brain shows that increases in protein levels with new Alzheimer’s drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques. During a study challenging the idea that newly approved monoclonal antibodies...
